Novartis/Aventis Consumer Products Combo Would Be Divested

Novartis would spin-off a combination of its consumer health products and Aventis' older drugs if the two companies were to merge

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet